Turkish pharma market reaches $23bn despite pricing challenges
This article was originally published in Scrip
Executive Summary
The Turkish pharmaceutical market is expected to reach a value of $22.8bn by 2015 with renewed investment from foreign multinationals, according to a report from the CPhI. But the country's pricing and reimbursement system presents a significant challenge for industry.